HCW Biologics Inc. is trading at $1.25 (-5.19%) as investors weigh a key Nasdaq compliance deadline and a recently announced plan for a large stockholder share sale.
- Today marks the 20th consecutive trading day the stock needed to close above $1.00 to regain compliance with Nasdaq listing requirements.
- The downward pressure also follows a June 8 filing indicating a stockholder plans to sell up to 5.69 million shares.